Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics

Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium’s Existing ADHD Portfolio –– Extends ...

Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress

Generated Quarterly Net Revenues of $193.5 Million, Up 9% Year-over-Year – – Generated JORNAY PM®Quarterly Net Revenue of $38.9 Million, Up 36% ...

Collegium Pharmaceutical, Inc.: Collegium Completes Acquisition of AZSTARYS from Corium Therapeutics

Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium's Existing ADHD Portfolio - - Extends Collegium's Long-Term Revenue Outlook; AZSTARYS has Expected ...

Are we all starting to sound the same? The GPTfication of the human voice

Is your "AI-radar" tingling? From the Shy Girl controversy to the "emotional iceberg" of human prose, explore why ...